Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Breast Neoplasms × Educational Status × Clear all

Phase

Status

Completed 22 Recruiting 11 Active not recruiting 7 Unknown 3 Withdrawn 1 Terminated 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Stress Disorders, Post-Traumatic 1 Sedentary Behavior 1 Pulmonary Disease, Chronic Obstructive 1 Prostate Adenocarcinoma 1 Pain 1 Overweight 1 Obesity 1 Motor Activity 1 Melanoma 1 Lung Neoplasms 1 Leukemia 1 Digestive System Neoplasms 1 Depression 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Arthralgia 1 Anxiety Disorders 1

Interventions

Trastuzumab 77 Capecitabine 59 Cyclophosphamide 54 Paclitaxel 51 Docetaxel 49 Letrozole 44 Fulvestrant 43 Lapatinib 33 Doxorubicin 31 Vinorelbine 30 Carboplatin 30 Bevacizumab 28 Anastrozole 28 pembrolizumab 24 exemestane 24 Tamoxifen 23 Gemcitabine 22 Radiotherapy 21 Albumin-Bound Paclitaxel 19 Everolimus 17 Taxes 16 Epirubicin 15 Ado-Trastuzumab Emtansine 13 130-nm albumin-bound paclitaxel 13 pertuzumab 12 palbociclib 12 liposomal doxorubicin 11 Magnetic Resonance Spectroscopy 11 Filgrastim 11 Cisplatin 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01351844 2017-08-30

CEASE

George Washington University

Phase NA Terminated

Breast Neoplasms, Motor Activity, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡